On his last day in San Francisco for JP Morgan 2023, editor-in-chief Jonah Comstock connected to Michelle Longmire, CEO of Medable, at the Grand Hyatt hotel.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh